<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9277499" created="03/06/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9277499</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Distinct mechanisms for <term id="T1" lex="N-acetylcysteine_inhibition" sem="Other"><term id="T2" lex="N-acetylcysteine" sem="Amino_acid_monomer">N-acetylcysteine</term> inhibition</term> of <term id="T3" lex="cytokine-induced_E-selectin" sem="Protein_molecule"><term id="A1" sem="Protein_family_or_group">cytokine</term>-induced <term id="A2" sem="Protein_molecule">E-selectin</term></term> and <term id="T4" lex="VCAM-1_expression" sem="Other"><term id="T5" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term> expression</term>.</sentence>
<event KT="Investigation" id="E1">
<type class="Negative_regulation"/>
<theme idref="E3"/>
<cause idref="T2"/>
<clue>Distinct mechanisms for N-acetylcysteine <clueType>inhibition</clueType> <linkTheme>of</linkTheme> cytokine-induced E-selectin and VCAM-1 expression.</clue>
</event>
<event KT="Investigation" id="E2">
<type class="Negative_regulation"/>
<theme idref="E49"/>
<cause idref="T2"/>
<clue>Distinct mechanisms for N-acetylcysteine <clueType>inhibition</clueType> <linkTheme>of</linkTheme> cytokine-induced E-selectin and VCAM-1 expression.</clue>
</event>
<event KT="Other" id="E3">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<cause idref="A1"/>
<clue>Distinct mechanisms for N-acetylcysteine inhibition of cytokine-<clueType>induced</clueType> E-selectin and VCAM-1 expression.</clue>
</event>
<event KT="Other" id="E49">
<type class="Positive_regulation"/>
<theme idref="E50"/>
<cause idref="A1"/>
<clue>Distinct mechanisms for N-acetylcysteine inhibition of cytokine-<clueType>induced</clueType> E-selectin and VCAM-1 expression.</clue>
</event>
<event KT="Other" id="E4">
<type class="Gene_expression"/>
<theme idref="A2"/>
<clue>Distinct mechanisms for N-acetylcysteine inhibition of cytokine-induced E-selectin and VCAM-1 <clueType>expression</clueType>.</clue>
</event>
<event KT="Other" id="E50">
<type class="Gene_expression"/>
<theme idref="T5"/>
<clue>Distinct mechanisms for N-acetylcysteine inhibition of cytokine-induced E-selectin and VCAM-1 <clueType>expression</clueType>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">We have examined the effects of <term id="T6" lex="N-acetyl-L-cysteine" sem="Amino_acid_monomer">N-acetyl-L-cysteine</term> (<term id="T7" lex="NAC" sem="Amino_acid_monomer">NAC</term>), a well-characterized, <term id="T8" lex="thiol-containing_antioxidant" sem="Amino_acid_monomer">thiol-containing antioxidant</term>, on <term id="A3" sem="Organic_compound_other">agonist</term>-induced <term id="T9" sem="Other"><term id="A4" sem="Cell_natural">monocytic cell</term> adhesion</term> to <term id="T10" lex="endothelial_cell" sem="Cell_natural">endothelial cells</term> (<term id="T11" lex="EC" sem="Cell_natural">EC</term>).</sentence>
<event KT="Investigation" id="E5" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E7"/>
<cause idref="T7"/>
<clue>We have <clueKT>examined</clueKT> the <clueType>effects</clueType> <linkCause>of</linkCause> N-acetyl-L-cysteine (NAC), a well-characterized, thiol-containing antioxidant, <linkTheme>on</linkTheme> agonist-induced monocytic cell adhesion to endothelial cells (EC).</clue>
</event>
<event KT="Other" id="E6">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="A3"/>
<clue>We have examined the effects of N-acetyl-L-cysteine (NAC), a well-characterized, thiol-containing antioxidant, on agonist-<clueType>induced</clueType> monocytic cell adhesion to endothelial cells (EC).</clue>
</event>
<event KT="Other" id="E7">
<type class="Cell_adhesion"/>
<theme idref="A4"/>
<theme idref="T11"/>
<clue>We have examined the effects of N-acetyl-L-cysteine (NAC), a well-characterized, thiol-containing antioxidant, on agonist-induced monocytic cell <clueType>adhesion</clueType> <linkTheme>to</linkTheme> endothelial cells (EC).</clue>
</event>
<sentence id="S3"><term id="T12" lex="NAC" sem="Amino_acid_monomer">NAC</term> inhibited <term id="T13" lex="interleukin-1" sem="Protein_molecule">interleukin-1</term> (<term id="T14" lex="IL-1_beta" sem="Protein_molecule">IL-1 beta</term>)-induced, but not basal, adhesion with 50% inhibition at approximately 20 mM.</sentence>
<event id="E8">
<type class="Negative_regulation"/>
<theme idref="E9"/>
<cause idref="T12"/>
<clue>NAC <clueType>inhibited</clueType> interleukin-1 (IL-1 beta)-induced, but not basal, adhesion with 50% inhibition at approximately 20 mM.</clue>
</event>
<event KT="Other" id="E9">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T14"/>
<clue>NAC inhibited interleukin-1 (IL-1 beta)-<clueType>induced</clueType>, but not basal, <corefTheme>adhesion</corefTheme> with 50% inhibition at approximately 20 mM.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E54">
<type class="Negative_regulation"/>
<theme idref="E7"/>
<cause idref="T12"/>
<clue>NAC <clueType>inhibited</clueType> interleukin-1 (IL-1 beta)-induced, but <cluePolarity>not</cluePolarity> basal, <corefTheme>adhesion</corefTheme> with 50% inhibition at approximately 20 mM.</clue>
</event>
<sentence id="S4"><term id="T15" lex="monocytic_cell_adhesion" sem="Other"><term id="A5" sem="Cell_natural">Monocytic cell</term> adhesion</term> to <term id="T16" lex="EC" sem="Cell_natural">EC</term> in response to <term id="T17" lex="tumor_necrosis_factor-alpha" sem="Protein_molecule">tumor necrosis factor-alpha</term> (<term id="T18" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term>), <term id="T19" lex="lipopolysaccharide" sem="Lipid">lipopolysaccharide</term> (<term id="T20" lex="LPS" sem="Lipid">LPS</term>), <term id="T21" lex="alpha-thrombin" sem="Protein_molecule">alpha-thrombin</term>, or <term id="T22" lex="phorbol_12-myristate_13-acetate" sem="Organic_compound_other">phorbol 12-myristate 13-acetate</term> (<term id="T23" lex="PMA" sem="Organic_compound_other">PMA</term>) was similarly inhibited by <term id="T24" lex="NAC" sem="Amino_acid_monomer">NAC</term>.</sentence>
<event KT="Other" id="E10">
<type class="Cell_adhesion"/>
<theme idref="A5"/>
<theme idref="T16"/>
<clue>Monocytic cell <clueType>adhesion</clueType> <linkTheme>to</linkTheme> EC in response to tumor necrosis factor-alpha (TNF-alpha), lipopolysaccharide (LPS), alpha-thrombin, or phorbol 12-myristate 13-acetate (PMA) was similarly inhibited by NAC.</clue>
</event>
<event KT="Other" id="E58">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="T18"/>
<clue>Monocytic cell adhesion to EC <linkCause>in response to</linkCause> tumor necrosis factor-alpha (TNF-alpha), lipopolysaccharide (LPS), alpha-thrombin, or phorbol 12-myristate 13-acetate (PMA) was similarly inhibited by NAC.</clue>
</event>
<event KT="Other" id="E11">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="T20"/>
<clue>Monocytic cell adhesion to EC <linkCause>in response to</linkCause> tumor necrosis factor-alpha (TNF-alpha), lipopolysaccharide (LPS), alpha-thrombin, or phorbol 12-myristate 13-acetate (PMA) was similarly inhibited by NAC.</clue>
</event>
<event KT="Other" id="E12">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="T21"/>
<clue>Monocytic cell adhesion to EC <linkCause>in response to</linkCause> tumor necrosis factor-alpha (TNF-alpha), lipopolysaccharide (LPS), alpha-thrombin, or phorbol 12-myristate 13-acetate (PMA) was similarly inhibited by NAC.</clue>
</event>
<event KT="Other" id="E13">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="T23"/>
<clue>Monocytic cell adhesion to EC <linkCause>in response to</linkCause> tumor necrosis factor-alpha (TNF-alpha), lipopolysaccharide (LPS), alpha-thrombin, or phorbol 12-myristate 13-acetate (PMA) was similarly inhibited by NAC.</clue>
</event>
<event id="E14">
<type class="Negative_regulation"/>
<theme idref="E58"/>
<cause idref="T24"/>
<clue>Monocytic cell adhesion to EC in response to tumor necrosis factor-alpha (TNF-alpha), lipopolysaccharide (LPS), alpha-thrombin, or phorbol 12-myristate 13-acetate (PMA) was similarly <clueType>inhibited</clueType> <linkCause>by</linkCause> NAC.</clue>
</event>
<event id="E15">
<type class="Negative_regulation"/>
<theme idref="E11"/>
<cause idref="T24"/>
<clue>Monocytic cell adhesion to EC in response to tumor necrosis factor-alpha (TNF-alpha), lipopolysaccharide (LPS), alpha-thrombin, or phorbol 12-myristate 13-acetate (PMA) was similarly <clueType>inhibited</clueType> <linkCause>by</linkCause> NAC.</clue>
</event>
<event id="E16">
<type class="Negative_regulation"/>
<theme idref="E12"/>
<cause idref="T24"/>
<clue>Monocytic cell adhesion to EC in response to tumor necrosis factor-alpha (TNF-alpha), lipopolysaccharide (LPS), alpha-thrombin, or phorbol 12-myristate 13-acetate (PMA) was similarly <clueType>inhibited</clueType> <linkCause>by</linkCause> NAC.</clue>
</event>
<event id="E17">
<type class="Negative_regulation"/>
<theme idref="E13"/>
<cause idref="T24"/>
<clue>Monocytic cell adhesion to EC in response to tumor necrosis factor-alpha (TNF-alpha), lipopolysaccharide (LPS), alpha-thrombin, or phorbol 12-myristate 13-acetate (PMA) was similarly <clueType>inhibited</clueType> <linkCause>by</linkCause> NAC.</clue>
</event>
<sentence id="S5">Unlike published studies with <term id="T25" lex="pyrrolidinedithiocarbamate" sem="Organic_compound_other">pyrrolidinedithiocarbamate</term>, which specifically inhibited <term id="T26" lex="vascular_cell_adhesion_molecule_1" sem="Protein_molecule">vascular cell adhesion molecule 1</term> (<term id="T27" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term>), <term id="T28" lex="NAC" sem="Amino_acid_monomer">NAC</term> inhibited <term id="T29" lex="IL-1_beta-induced_mRNA" sem="RNA_family_or_group"><term id="T30" lex="IL-1_beta" sem="Protein_molecule">IL-1 beta</term>-induced <term id="A18" sem="RNA_family_or_group">mRNA</term></term> and cell surface expression of both <term id="T31" lex="E-selectin" sem="Protein_molecule"><term id="A16" sem="RNA_family_or_group">E-selectin</term></term> and <term id="T32" lex="VCAM-1" sem="Protein_molecule"><term id="A17" sem="RNA_family_or_group">VCAM-1</term></term>.</sentence>
<event Source="Other" id="E18">
<type class="Negative_regulation"/>
<theme idref="T27"/>
<cause idref="T25"/>
<clue>Unlike <clueSource>published studies</clueSource> with pyrrolidinedithiocarbamate, which specifically <clueType>inhibited</clueType> vascular cell adhesion molecule 1 (VCAM-1), NAC inhibited IL-1 beta-induced mRNA and cell surface expression of both E-selectin and VCAM-1.</clue>
</event>
<event id="E19">
<type class="Negative_regulation"/>
<theme idref="E27"/>
<cause idref="T28"/>
<clue>Unlike published studies with pyrrolidinedithiocarbamate, which specifically inhibited vascular cell adhesion molecule 1 (VCAM-1), NAC <clueType>inhibited</clueType> IL-1 beta-induced mRNA and cell surface expression of both E-selectin and VCAM-1.</clue>
</event>
<event id="E20">
<type class="Negative_regulation"/>
<theme idref="E28"/>
<cause idref="T28"/>
<clue>Unlike published studies with pyrrolidinedithiocarbamate, which specifically inhibited vascular cell adhesion molecule 1 (VCAM-1), NAC <clueType>inhibited</clueType> IL-1 beta-induced mRNA and cell surface expression of both E-selectin and VCAM-1.</clue>
</event>
<event id="E21">
<type class="Negative_regulation"/>
<theme idref="E29"/>
<cause idref="T28"/>
<clue>Unlike published studies with pyrrolidinedithiocarbamate, which specifically inhibited vascular cell adhesion molecule 1 (VCAM-1), NAC <clueType>inhibited</clueType> IL-1 beta-induced mRNA and cell surface expression of both E-selectin and VCAM-1.</clue>
</event>
<event id="E22">
<type class="Negative_regulation"/>
<theme idref="E30"/>
<cause idref="T28"/>
<clue>Unlike published studies with pyrrolidinedithiocarbamate, which specifically inhibited vascular cell adhesion molecule 1 (VCAM-1), NAC <clueType>inhibited</clueType> IL-1 beta-induced mRNA and cell surface expression of both E-selectin and VCAM-1.</clue>
</event>
<event KT="Other" id="E23">
<type class="Transcription"/>
<theme idref="A16"/>
<clue>Unlike published studies with pyrrolidinedithiocarbamate, which specifically inhibited vascular cell adhesion molecule 1 (VCAM-1), NAC inhibited IL-1 beta-induced <clueType>mRNA</clueType> and cell surface <clueType>expression</clueType> <linkTheme>of</linkTheme> both E-selectin and VCAM-1.</clue>
</event>
<event KT="Other" id="E24">
<type class="Transcription"/>
<theme idref="A17"/>
<clue>Unlike published studies with pyrrolidinedithiocarbamate, which specifically inhibited vascular cell adhesion molecule 1 (VCAM-1), NAC inhibited IL-1 beta-induced <clueType>mRNA</clueType> and cell surface <clueType>expression</clueType> <linkTheme>of</linkTheme> both E-selectin and VCAM-1.</clue>
</event>
<event KT="Other" id="E25">
<type class="Gene_expression"/>
<theme idref="T31"/>
<clue>Unlike published studies with pyrrolidinedithiocarbamate, which specifically inhibited vascular cell adhesion molecule 1 (VCAM-1), NAC inhibited IL-1 beta-induced mRNA and <clueLoc>cell surface</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> both E-selectin and VCAM-1.</clue>
</event>
<event KT="Other" id="E26">
<type class="Gene_expression"/>
<theme idref="T32"/>
<clue>Unlike published studies with pyrrolidinedithiocarbamate, which specifically inhibited vascular cell adhesion molecule 1 (VCAM-1), NAC inhibited IL-1 beta-induced mRNA and <clueLoc>cell surface</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> both E-selectin and VCAM-1.</clue>
</event>
<event KT="Other" id="E27">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<cause idref="T30"/>
<clue>Unlike published studies with pyrrolidinedithiocarbamate, which specifically inhibited vascular cell adhesion molecule 1 (VCAM-1), NAC inhibited IL-1 beta-<clueType>induced</clueType> mRNA and cell surface expression of both E-selectin and VCAM-1.</clue>
</event>
<event KT="Other" id="E28">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<cause idref="T30"/>
<clue>Unlike published studies with pyrrolidinedithiocarbamate, which specifically inhibited vascular cell adhesion molecule 1 (VCAM-1), NAC inhibited IL-1 beta-<clueType>induced</clueType> mRNA and cell surface expression of both E-selectin and VCAM-1.</clue>
</event>
<event KT="Other" id="E29">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<cause idref="T30"/>
<clue>Unlike published studies with pyrrolidinedithiocarbamate, which specifically inhibited vascular cell adhesion molecule 1 (VCAM-1), NAC inhibited IL-1 beta-<clueType>induced</clueType> mRNA and cell surface expression of both E-selectin and VCAM-1.</clue>
</event>
<event KT="Other" id="E30">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<cause idref="T30"/>
<clue>Unlike published studies with pyrrolidinedithiocarbamate, which specifically inhibited vascular cell adhesion molecule 1 (VCAM-1), NAC inhibited IL-1 beta-<clueType>induced</clueType> mRNA and cell surface expression of both E-selectin and VCAM-1.</clue>
</event>
<sentence id="S6"><term id="T33" lex="NAC" sem="Amino_acid_monomer">NAC</term> had no effect on the half-life of <cons id="T34" lex="(OR E-selectin_mRNA VCAM-1_mRNA)" sem="(OR RNA_molecule RNA_molecule)"><frag id="F1"><term id="A7" sem="RNA_molecule">E-selectin</term></frag> or <frag id="F2"><term id="A8" sem="RNA_molecule">VCAM-1</term></frag> <frag id="F3"><term id="A9" sem="RNA_molecule">mRNA</term></frag></cons>.</sentence>
<event Polarity="Negative" assertion="non-exist" id="E31">
<type class="Regulation"/>
<theme idref="A7" idref1="A9"/>
<cause idref="T33"/>
<clue>NAC had <cluePolarity>no</cluePolarity> <clueType>effect on the half-life</clueType> <linkTheme>of</linkTheme> E-selectin or VCAM-1 mRNA.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E32">
<type class="Regulation"/>
<theme idref="A8" idref1="A9"/>
<cause idref="T33"/>
<clue>NAC had <cluePolarity>no</cluePolarity> <clueType>effect on the half-life</clueType> <linkTheme>of</linkTheme> E-selectin or VCAM-1 mRNA.</clue>
</event>
<sentence id="S7">Although <term id="T35" lex="NAC" sem="Amino_acid_monomer">NAC</term> reduced <term id="T36" lex="nuclear_factor-kappa_B_(NF-kappa_B)_activation" sem="Other"><term id="T37" lex="nuclear_factor-kappa_B" sem="Protein_complex">nuclear factor-kappa B</term> (<term id="T38" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>) activation</term> in <term id="T39" lex="EC" sem="Cell_natural">EC</term> as measured by <term id="T40" lex="gel-shift_assay" sem="Other">gel-shift assays</term> using an <term id="T41" lex="oligonucleotide_probe" sem="DNA_family_or_group">oligonucleotide probe</term> corresponding to the consensus <term id="T42" lex="NF-kappa_B_binding_sites" sem="DNA_domain_or_region"><term id="T43" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> binding sites</term> of the <term id="T44" lex="VCAM-1_gene" sem="DNA_domain_or_region"><term id="T45" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term> gene</term> (<term id="T46" lex="VCAM-NF-kappa_B" sem="Protein_complex">VCAM-<term id="T47" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term></term>), the antioxidant had no appreciable effect when an oligomer corresponding to the <term id="T48" lex="consensus_NF-kappa_B_binding_site" sem="DNA_domain_or_region">consensus <term id="T49" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> binding site</term> of the <term id="T50" lex="E-selectin_gene" sem="DNA_domain_or_region"><term id="T51" lex="E-selectin" sem="Protein_molecule">E-selectin</term> gene</term> (<term id="T52" lex="E-selectin" sem="Protein_molecule">E-selectin</term><term id="T53" lex="NF-kappa_B" sem="Protein_complex">-NF-kappa B</term>) was used.</sentence>
<event id="E33">
<type class="Negative_regulation"/>
<theme idref="E34"/>
<cause idref="T35"/>
<clue>Although NAC <clueType>reduced</clueType> nuclear factor-kappa B (NF-kappa B) activation <clueLoc>in EC</clueLoc> as measured <clueExperiment>by gel-shift assays using an oligonucleotide probe corresponding to the consensus NF-kappa B binding sites of the VCAM-1 gene (VCAM-NF-kappa B)</clueExperiment>, the antioxidant had no appreciable effect when an oligomer corresponding to the consensus NF-kappa B binding site of the E-selectin gene (E-selectin-NF-kappa B) was used.</clue>
</event>
<event id="E34">
<type class="Positive_regulation"/>
<theme idref="T38"/>
<clue>Although NAC reduced nuclear factor-kappa B (NF-kappa B) <clueType>activation</clueType> in EC as measured by gel-shift assays using an oligonucleotide probe corresponding to the consensus NF-kappa B binding sites of the VCAM-1 gene (VCAM-NF-kappa B), the antioxidant had no appreciable effect when an oligomer corresponding to the consensus NF-kappa B binding site of the E-selectin gene (E-selectin-NF-kappa B) was used.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E35">
<type class="Regulation"/>
<theme idref="E34"/>
<cause idref="T35"/>
<clue>Although NAC reduced nuclear factor-kappa B (NF-kappa B) activation in EC as measured <clueExperiment>by gel-shift assays</clueExperiment> using an oligonucleotide probe corresponding to the consensus NF-kappa B binding sites of the VCAM-1 gene (VCAM-NF-kappa B), <corefCause>the antioxidant</corefCause> had <cluePolarity>no</cluePolarity> appreciable <clueType>effect</clueType> <clueExperiment>when an oligomer corresponding to the consensus NF-kappa B binding site of the E-selectin gene (E-selectin-NF-kappa B) was used</clueExperiment>.</clue>
</event>
<sentence id="S8">Because <term id="T54" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> has been reported to be <term id="A14" sem="Other">redox</term> sensitive, we studied the effects of <term id="T55" lex="NAC" sem="Amino_acid_monomer">NAC</term> on the <term id="T56" lex="EC_redox_environment" sem="Other"><term id="T57" lex="EC" sem="Cell_natural">EC</term> redox environment</term>.</sentence>
<event KT="Analysis" Source="Other" id="E51">
<type class="Regulation"/>
<theme idref="T54"/>
<cause idref="A14"/>
<clue>Because NF-kappa B <clueSource>has been</clueSource> <clueKT>reported</clueKT> to be redox <clueType>sensitive</clueType>, we studied the effects of NAC on the EC redox environment.</clue>
</event>
<event KT="Investigation" id="E36" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="T56"/>
<cause idref="T55"/>
<clue>Because NF-kappa B has been reported to be redox sensitive, we <clueKT>studied</clueKT> the <clueType>effects</clueType> <linkCause>of</linkCause> NAC <linkTheme>on</linkTheme> the EC redox environment.</clue>
</event>
<sentence id="S9"><term id="T58" lex="NAC" sem="Amino_acid_monomer">NAC</term> caused an expected dramatic increase in the <term id="T60" lex="reduced_glutathione" sem="Peptide">reduced glutathione</term> (<term id="T61" lex="GSH" sem="Peptide">GSH</term>) levels in <term id="T62" lex="EC" sem="Cell_natural">EC</term>.</sentence>
<event Manner="High" id="E37">
<type class="Positive_regulation"/>
<theme idref="T61"/>
<cause idref="T58"/>
<clue>NAC <clueType>caused</clueType> an expected <clueManner>dramatic</clueManner> <clueType>increase</clueType> <linkTheme>in</linkTheme> the reduced glutathione (GSH) levels <clueLoc>in EC</clueLoc>.</clue>
</event>
<sentence id="S10">In vitro studies demonstrated that whereas the binding affinity of <term id="T63" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> to the <term id="T64" lex="VCAM-NF-kappa_B_oligomer" sem="DNA_molecule">VCAM-<term id="T65" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> oligomer</term> peaked at a <term id="A19" sem="Other"><term id="T66" lex="GSH-to-oxidized_glutathione_(GSSG)_ratio" sem="Other"><term id="T67" lex="GSH" sem="Peptide">GSH</term>-to-oxidized <term id="T68" lex="glutathione" sem="Peptide">glutathione</term> (<term id="T69" lex="GSSG" sem="Peptide">GSSG</term>) ratio</term> of approximately 200</term> and decreased at <term id="A20" sem="Other">higher ratios</term>, the binding to the <term id="T70" lex="E-selectin-NF-kappa_B_oligomer" sem="DNA_molecule"><term id="T71" lex="E-selectin" sem="Protein_molecule">E-selectin</term><term id="T72" lex="NF-kappa_B" sem="Protein_complex">-NF-kappa B</term> oligomer</term> appeared relatively unaffected even at ratios &gt; 400, i.e., those achieved in <term id="T73" lex="EC" sem="Cell_natural">EC</term> treated with 40 mM <term id="T74" lex="NAC" sem="Amino_acid_monomer">NAC</term>.</sentence>
<event KT="Other" id="E38">
<type class="Binding"/>
<theme idref="T63"/>
<theme idref="T64"/>
<clue>In vitro studies demonstrated that whereas the <clueType>binding</clueType> affinity <linkTheme>of</linkTheme> NF-kappa B <linkTheme>to</linkTheme> the VCAM-NF-kappa B oligomer peaked at a GSH-to-oxidized glutathione (GSSG) ratio of approximately 200 and decreased at higher ratios, the binding to the E-selectin-NF-kappa B oligomer appeared relatively unaffected even at ratios &gt; 400, i.e., those achieved in EC treated with 40 mM NAC.</clue>
</event>
<event KT="Analysis" id="E39">
<type class="Positive_regulation"/>
<theme idref="E38"/>
<cause idref="A19"/>
<clue>In vitro studies <clueKT>demonstrated</clueKT> that whereas the binding affinity of NF-kappa B to the VCAM-NF-kappa B oligomer <clueType>peaked</clueType> <linkCause>at</linkCause> a GSH-to-oxidized glutathione (GSSG) ratio of approximately 200 and decreased at higher ratios, the binding to the E-selectin-NF-kappa B oligomer appeared relatively unaffected even at ratios &gt; 400, i.e., those achieved <clueLoc>in EC treated with 40 mM NAC</clueLoc>.</clue>
<comment>TPS: A19</comment></event>
<event KT="Analysis" id="E57">
<type class="Negative_regulation"/>
<theme idref="E39"/>
<cause idref="T66" idref1="A20"/>
<clue>In vitro studies <clueKT>demonstrated</clueKT> that whereas the binding affinity of NF-kappa B to the VCAM-NF-kappa B oligomer peaked at a GSH-to-oxidized glutathione (GSSG) ratio of approximately 200 and <clueType>decreased</clueType> <linkCause>at</linkCause> higher ratios, the binding to the E-selectin-NF-kappa B oligomer appeared relatively unaffected even at ratios &gt; 400, i.e., those achieved <clueLoc>in EC treated with 40 mM NAC</clueLoc>.</clue>
</event>
<event KT="Other" id="E40">
<type class="Binding"/>
<theme idref="T63"/>
<theme idref="T70"/>
<clue>In vitro studies demonstrated that whereas the binding affinity of NF-kappa B to the VCAM-NF-kappa B oligomer peaked at a GSH-to-oxidized glutathione (GSSG) ratio of approximately 200 and decreased at higher ratios, the <clueType>binding</clueType> <linkTheme>to</linkTheme> the E-selectin-NF-kappa B oligomer appeared relatively unaffected even at ratios &gt; 400, i.e., those achieved in EC treated with 40 mM NAC.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E41" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E40"/>
<cause idref="T66"/>
<clue>In vitro studies <clueKT>demonstrated</clueKT> that whereas the binding affinity of NF-kappa B to the VCAM-NF-kappa B oligomer peaked at a GSH-to-oxidized glutathione (GSSG) ratio of approximately 200 and decreased at higher ratios, the binding to the E-selectin-NF-kappa B oligomer <clueCL>appeared</clueCL> relatively <clueType><cluePolarity>unaffected</cluePolarity></clueType> even at ratios &gt; 400, i.e., those achieved <clueLoc>in EC treated with 40 mM NAC</clueLoc>.</clue>
</event>
<event KT="Method" id="E42">
<type class="Artificial_process"/>
<theme idref="T73"/>
<theme idref="T74"/>
<clue>In vitro studies demonstrated that whereas the binding affinity of NF-kappa B to the VCAM-NF-kappa B oligomer peaked at a GSH-to-oxidized glutathione (GSSG) ratio of approximately 200 and decreased at higher ratios, the binding to the E-selectin-NF-kappa B oligomer appeared relatively unaffected even at ratios &gt; 400, i.e., those achieved in EC <clueType>treated</clueType> <linkTheme>with</linkTheme> 40 mM NAC.</clue>
</event>
<sentence id="S11">These results suggest that <term id="T75" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> binding to its consensus sequences in the <term id="T76" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term> and <term id="T77" lex="E-selectin_gene" sem="DNA_domain_or_region"><term id="T78" lex="E-selectin" sem="Protein_molecule">E-selectin</term> <term id="A10" sem="DNA_domain_or_region">gene</term></term> exhibits marked differences in <term id="A15" sem="Other">redox sensitivity</term>, allowing for differential <term id="A11" sem="Other">gene expression</term> regulated by the same transcription factor.</sentence>
<event KT="Other" id="E43">
<type class="Binding"/>
<theme idref="T75"/>
<theme idref="A10" idref1="T76"/>
<clue>These results suggest that NF-kappa B <clueType>binding</clueType> <linkTheme>to</linkTheme> its consensus sequences in the VCAM-1 and E-selectin gene exhibits marked differences in redox sensitivity, allowing for differential gene expression regulated by the same transcription factor.</clue>
</event>
<event KT="Other" id="E44">
<type class="Binding"/>
<theme idref="T75"/>
<theme idref="A10" idref1="T78"/>
<clue>These results suggest that NF-kappa B <clueType>binding</clueType> <linkTheme>to</linkTheme> its consensus sequences in the VCAM-1 and E-selectin gene exhibits marked differences in redox sensitivity, allowing for differential gene expression regulated by the same transcription factor.</clue>
</event>
<event KT="Other" id="E45" uncertainty="probable">
<type class="Regulation"/>
<theme idref="A11"/>
<cause idref="T75"/>
<clue>These results suggest that NF-kappa B binding to its consensus sequences in the VCAM-1 and E-selectin gene exhibits marked differences in redox sensitivity, allowing for differential gene expression <clueType>regulated</clueType> <linkCause>by</linkCause> <corefCause>the same transcription factor</corefCause>.</clue>
</event>
<event CL="L2" KT="Analysis" id="E52" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E45"/>
<cause idref="A15"/>
<clue>These results <clueKT><clueCL>suggest</clueCL></clueKT> that NF-kappa B binding to its consensus sequences in the VCAM-1 and E-selectin gene exhibits marked differences in redox sensitivity, <clueType>allowing</clueType> <linkTheme>for</linkTheme> differential gene expression regulated by the same transcription factor.</clue>
</event>
<sentence id="S12">Our data also demonstrate that <term id="T79" lex="NAC" sem="Amino_acid_monomer">NAC</term> increases the <term id="T80" lex="GSH-to-GSSG_ratio" sem="Other"><term id="T81" lex="GSH" sem="Peptide">GSH</term>-to-<term id="T82" lex="GSSG" sem="Peptide">GSSG</term> ratio</term> within the <term id="T83" lex="EC" sem="Cell_natural">EC</term> suggesting one possible mechanism through which this antioxidant inhibits <term id="A12" sem="Organic_compound_other">agonist</term>-induced <term id="T59" sem="Other"><term id="A13" sem="Cell_natural">monocyte</term> adhesion</term> to <term id="T85" lex="EC" sem="Cell_natural">EC</term>.</sentence>
<event KT="Analysis" id="E46">
<type class="Positive_regulation"/>
<theme idref="T80"/>
<cause idref="T79"/>
<clue>Our data also <clueKT>demonstrate</clueKT> that NAC <clueType>increases</clueType> the GSH-to-GSSG ratio <clueLoc>within the EC</clueLoc> suggesting one possible mechanism through which this antioxidant inhibits agonist-induced monocyte adhesion to EC.</clue>
</event>
<event CL="L1" KT="Analysis" id="E47" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="E48"/>
<cause idref="T81"/>
<clue>Our data also demonstrate that NAC increases the GSH-to-GSSG ratio within the EC <clueKT>suggesting</clueKT> one <clueCL>possible</clueCL> mechanism through which <corefCause>this antioxidant</corefCause> <clueType>inhibits</clueType> agonist-induced monocyte adhesion to EC.</clue>
</event>
<event KT="Other" id="E48">
<type class="Cell_adhesion"/>
<theme idref="A13"/>
<theme idref="T85"/>
<clue>Our data also demonstrate that NAC increases the GSH-to-GSSG ratio within the EC suggesting one possible mechanism through which this antioxidant inhibits agonist<linkCause>-induced</linkCause> monocyte <clueType>adhesion</clueType> <linkTheme>to</linkTheme> EC.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
